{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:16:56Z","timestamp":1789532216966,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.06.020","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:24:16Z","timestamp":1720531456000},"page":"2702-2712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs"],"prefix":"10.1016","volume":"22","author":[{"given":"M\u00e9lanie Y.","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ternisien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Castet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Falaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"D\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Volot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Itzhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Pan-Petesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Jeanpierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Zawadzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Desvages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Repess\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Babuty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Trossa\u00ebrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lenting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5953-163X","authenticated-orcid":false,"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.06.020_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0031-1281038","article-title":"The diagnosis and management of von Willebrand disease in Canada","volume":"37","author":"James","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0031-1281033","article-title":"Diagnosis and management of von Willebrand disease in the United Kingdom","volume":"37","author":"Keeney","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0031-1281032","article-title":"Diagnosis and management of von Willebrand disease in the Netherlands","volume":"37","author":"de Wee","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.V124.21.472.472","article-title":"Spectrum of type 2 von Willebrand disease in the Zimmerman Program","volume":"124","author":"Flood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003038","article-title":"French Reference Center for von Willebrand disease. A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtha.2024.06.020_bib6","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"Borr\u00e0s","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.06.020_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.21037\/atm.2018.09.10","article-title":"Rare forms of von Willebrand disease","volume":"6","author":"Favaloro","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jtha.2024.06.020_bib8","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.020_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.020_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A\u00a0new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The \u201cNormandy\u201d variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene","volume":"77","author":"Gaucher","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib13","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.88.14.6377","article-title":"Expression of von Willebrand factor \u201cNormandy\u201d: an autosomal mutation that mimics hemophilia A","volume":"88","author":"Tuley","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.06.020_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (\u2018Normandy\u2019) von Willebrand disease. Collaborative group","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.06.020_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1309\/2D6F-RR03-8EFN-28F5","article-title":"Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods","volume":"118","author":"Rodgers","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2024.06.020_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000214852","article-title":"Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1","volume":"121","author":"Michiels","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2024.06.020_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/pbc.23120","article-title":"Therapeutic consequences for misdiagnosis of type 2N von Willebrand disease","volume":"57","author":"Gupta","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtha.2024.06.020_bib18","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1111\/hae.12733","article-title":"Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype","volume":"21","author":"van Meegeren","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.020_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/hae.13366","article-title":"Type 2N von Willebrand disease: characterization and diagnostic difficulties","volume":"24","author":"Casonato","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.020_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12185-019-02814-8","article-title":"Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience","volume":"111","author":"Rassoulzadegan","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2024.06.020_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/hae.14405","article-title":"Type 2N VWD: conclusions from the Spanish PCM-EVW-ES project","volume":"27","author":"P\u00e9rez-Rodr\u00edguez","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.020_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A\u00a0quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0040-1713735","article-title":"Navigating the myriad of von Willebrand factor Assays","volume":"40","author":"Favaloro","year":"2020","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.jtha.2024.06.020_bib24","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-0037-1613249","article-title":"First Italian families with homozygous R854Q type 2 N von Willebrand disease","volume":"88","author":"Castaman","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2516.2011.02499.x","article-title":"Validation of the first commercial ELISA for type 2N von Willebrand\u2019s disease diagnosis","volume":"17","author":"Veyradier","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.020_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","article-title":"Recessive inheritance of von Willebrand\u2019s disease type I","volume":"341","author":"Eikenboom","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.06.020_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1615134","article-title":"Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)\u2014detection of a novel candidate type 2N mutation: C2810T (R854W)","volume":"80","author":"Bowen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib29","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3324\/haematol.2012.066019","article-title":"A\u00a0common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand\u2019s disease in Italy","volume":"98","author":"Casonato","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.06.020_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases","volume":"8","author":"Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jtha.2024.06.020_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.020_bib33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.13749","article-title":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","volume":"15","author":"Swystun","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00043426-200311000-00010","article-title":"Desmopressin (DDAVP) responsiveness in children with von Willebrand disease","volume":"25","author":"Revel-Vilk","year":"2003","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.06.020_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2516.2006.01273.x","article-title":"Von Willebrand\u2019s disease: clinical management","volume":"12","author":"Federici","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.06.020_bib36","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1182\/bloodadvances.2021006757","article-title":"Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease","volume":"6","author":"Atiq","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.020_bib37","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood.2019001292","article-title":"BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice","volume":"135","author":"Seth Chhabra","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.06.020_bib38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa2002699","article-title":"BIVV001 fusion protein as factor VIII replacement therapy for hemophilia A","volume":"383","author":"Konkle","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.06.020_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jth.15741","article-title":"Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII","volume":"20","author":"Demers","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-023-01866-9","article-title":"Efanesoctocog alfa: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2024.06.020_bib41","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1016\/j.jtha.2023.09.009","article-title":"Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa","volume":"21","author":"Ryu","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.020_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2020.11.026","article-title":"Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditions","volume":"198","author":"Yaoi","year":"2021","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:45:39Z","timestamp":1759351539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003817"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}